Answers are grounded in this paper and cite their sources.
One of the fundamental principles guiding the pharmaceutical quality of parenteral products is to prevent injecting contaminants from microbiological, chemical or physical sources. It is just as difficult to ensure the absence of chemical and particulate contaminants in injectable products as it is to weigh up the microbiological risk. The problem of particulate matter is mainly related to the preparing and administrating of injectable drugs rather than through the contamination of marketed products. Particulate contamination also arises
No takes yet. Share an insight, caveat, or question.
Perez et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: